Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Liver Failure × sacituzumab govitecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 3 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Localized Muscle Invasive Bladder Urothelial Carcinoma 1 Liver Failure 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Solid Tumors 1

Interventions

sacituzumab govitecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04617522 2026-02-11

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

Gilead Sciences

Phase 1 Recruiting

Neoplasm Metastasis, Liver Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡